Drug Overdose Clinical Trial
Official title:
Bioavailability of Nasal Naloxone and Injected Naloxone Compared. A Randomized, Open Label, 4-way Cross-over Study
Opioid overdoses have in the last decade counted for about 230 untimely deaths annually in
Norway. The government is currently implementing a strategy for combating this epidemic.
Among the actions promoted in this strategy is the distribution of naloxone for intranasal
administration. Such administration of naloxone is currently being implemented and tried out
around the world, but very little has been done to pharmacologically study this new route of
administration of this well known drug, and only 3 open label randomized controlled trials
(RCTs) have been conducted. A recent guideline from the WHO on community management of
opioid overdoses is a comprehensive review of many of the aspects the investigators cover in
our research.
Regarding both dosage, routes of administration of naloxone and care of these patients in
the pre hospital setting. The WHO calls for nasal formulations with a higher concentration,
as well as focuses on the current wide spread off label use of nasal naloxone as a problem
and identifies several research questions of critical importance and very low evidence.The
current study, together with our research group's previous and future studies, aims to
provide data for the development of a medicinal product with marketing authorisation for use
in pre-hospital overdoses. This to contribute to public health measures for opioid users and
those around them.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04070521 -
EEG Monitoring in the Emergency Department
|
||
Completed |
NCT04372238 -
The Rhode Island Prescription and Illicit Drug Study
|
N/A | |
Withdrawn |
NCT04391192 -
Virtual Overdose Response
|
N/A | |
Completed |
NCT02924454 -
Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.
|
Phase 4 | |
Completed |
NCT02282306 -
Phone Interview to Prevent Recurring Opioid Overdoses
|
N/A | |
Not yet recruiting |
NCT01912573 -
Nasal Naloxone for Narcotic Overdose
|
Phase 4 | |
Completed |
NCT04091659 -
Use of Virtual Reality for Overdose Management Educational Trainings
|
N/A | |
Recruiting |
NCT05517668 -
Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
|
Phase 2 | |
Completed |
NCT02152397 -
Safety and Health Intervention Project
|
N/A | |
Completed |
NCT02572089 -
Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT05096429 -
Preventing Overdose Using Information and Data From the Environment
|
N/A | |
Recruiting |
NCT03845699 -
Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose
|
||
Completed |
NCT03840018 -
Effectiveness of a Postal Intervention to Improve the Use of PPI
|
N/A | |
Recruiting |
NCT06327061 -
Social Network Overdose Prevention and Education Intervention
|
N/A | |
Completed |
NCT03087149 -
Monitored vs Standard Supplementation of Vitamin D in Preterm Infants
|
N/A | |
Active, not recruiting |
NCT05657106 -
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
|
N/A | |
Completed |
NCT02158117 -
Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use
|
Phase 1 | |
Recruiting |
NCT05146336 -
CytOSorb TreatMent Of Critically Ill PatientS Registry
|
||
Not yet recruiting |
NCT02733822 -
Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study
|
Phase 1 | |
Active, not recruiting |
NCT05308303 -
AI to Improve Data From Danish Cardiac Arrest Registry
|